DPAM
MRNA icon

Degroof Petercam Asset Management’s Moderna MRNA Stock Holding History

Degroof Petercam Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$762K Hold
7,147
– – 0.01% 446
2023
Q4 		$711K Buy
+7,147
New +$601K 0.01% 451

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Degroof Petercam Asset Management's MRNA Position: Q1 2024 in Review

Degroof Petercam Asset Management held its Moderna (MRNA) position steady in Q1 2024 at 7,147 shares worth $762K. The position accounts for 0.01% of the portfolio, ranked #446.

Degroof Petercam Asset Management first reported a position in MRNA in Q4 2023 and has held it in 2 quarters since. 903 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • Degroof Petercam Asset Management held 7,147 shares of Moderna worth $762K as of Q1 2024.
  • Degroof Petercam Asset Management left its Moderna share count unchanged in Q1 2024.
  • Moderna made up 0.01% of Degroof Petercam Asset Management's portfolio in Q1 2024, its #446 holding.
  • Degroof Petercam Asset Management first reported a position in Moderna in Q4 2023 and has held it in 2 quarters since.
  • 903 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on Degroof Petercam Asset Management's 13F filing for Q1 2024, filed 13 May 2024.